Innovative Biopharmaceutical Ontologies Released for Enhanced Data Interoperability and Analytics NIIMBL and OAGi unveil essential ontologies to improve biopharmaceutical data interoperability, advancing manufacturing analytics and communications across the industry.

Innovative Biopharmaceutical Ontologies Released for Enhanced Data Interoperability and Analytics #United_States #biopharmaceuticals #Newark,_Delaware #NIIMBL #OAGi

NIIMBL-Led Team Secures $10.5 Million Funding for Monoclonal Antibody Manufacturing Innovations The NIIMBL-led collaboration has been awarded $10.5 million to revolutionize monoclonal antibody manufacturing, making therapies more accessible.

NIIMBL-Led Team Secures $10.5 Million Funding for Monoclonal Antibody Manufacturing Innovations #United_States #Gates_Foundation #Newark #Monoclonal_Antibodies #NIIMBL

NIIMBL Opens Applications for 2026 eXperience Program Across Five U.S. Locations Explore the exciting opportunities in biopharmaceutical careers! NIIMBL announces the opening of student applications for its immersive 2026 eXperience program.

NIIMBL Opens Applications for 2026 eXperience Program Across Five U.S. Locations #United_States #Newark #Biopharmaceutical #NIIMBL #eXperience_Program

NIIMBL Unveils New Funding Opportunity to Propel Biopharma Innovations Through Project Call 9.1 The National Institute for Innovation in Manufacturing Biopharmaceuticals has launched Project Call 9.1, offering $8 million for biopharmaceutical innovation.

NIIMBL Unveils New Funding Opportunity to Propel Biopharma Innovations Through Project Call 9.1 #United_States #Innovation #Newark #Biopharma #NIIMBL

NIIMBL Unveils 11 Transformative Projects for Biopharmaceutical Manufacturing The National Institute for Innovation in Manufacturing Biopharmaceuticals has launched 11 new projects aimed at enhancing workforce capabilities and technological advancements in the industry.

NIIMBL Unveils 11 Transformative Projects for Biopharmaceutical Manufacturing #United_States #Newark #biotechnology #NIIMBL #mRNA_Projects

NIIMBL Invites 100 Students to Engage in the Innovative 2025 eXperience Program NIIMBL announces the selection of 100 students for the 2025 eXperience program, aiming to inspire future talent in biopharmaceuticals.

NIIMBL Invites 100 Students to Engage in the Innovative 2025 eXperience Program #United_States #biopharmaceuticals #Newark #NIIMBL #eXperience_Program

Innovative AAV Production Process Funded by NIIMBL Grant: ChromaTan and Landmark Bio Collaborate ChromaTan and Landmark Bio receive NIIMBL funding to enhance AAV production for gene therapy. A significant step towards accessible treatments.

Innovative AAV Production Process Funded by NIIMBL Grant: ChromaTan and Landmark Bio Collaborate #United_States #NIIMBL #ChromaTan #Landmark_Bio #Spring_House,_Watertown

NIIMBL Introduces New Initiative to Enhance Next-Generation Sequencing in Gene Therapy The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has issued a request to optimize next-generation sequencing capabilities for gene therapy innovations. This aims to enhance patient outcomes.

NIIMBL Introduces New Initiative to Enhance Next-Generation Sequencing in Gene Therapy #USA #Newark #gene_therapy #NIIMBL #NGS